Trade Summary

2 days ago, Dickinson Andrew D, serving as Chief Financial Officer at GILEAD SCIENCES, INC. (GILD), sold 3,000 shares at $129.93 per share, for a total transaction value of $389,776.80. Following this transaction, Dickinson Andrew D now holds 168,646 shares of GILD.

This sale represents a 1.75% decrease in Dickinson Andrew D's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 6:08 PM ET, 1 day after the trade was made.

GILEAD SCIENCES, INC. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.